StockDrifts LogoStockDrifts

Stonepine Capital Management 13F Portfolio

Portfolio Manager
Stonepine Capital Management LLC
Performance
+6.80% (2026 Q2)
AUM (13F)
$177.26M
# of Holdings
72
Performance Rank
Allocation (Top 20)
73.07%
Latest filing
Q2 2026

Stonepine Capital Management LLC Holdings Map

Top 50 Stonepine Capital Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
VSTM
VERASTEM INC
9.74%3.35M$12.8M
+1.43%(+47.33K)
2025-Q2: 1.36M shares2025-Q3: 2.67M shares2025-Q4: 2.73M shares2026-Q1: 3.30M shares2026-Q2: 3.35M shares
$5.56(+23.83%)
2026-06-30
EOLS
EVOLUS INC
8.4%1.59M$11.0M
-9.60%(-168.93K)
2025-Q2: 916.5K shares2025-Q3: 1.54M shares2025-Q4: 1.63M shares2026-Q1: 1.76M shares2026-Q2: 1.59M shares
$7.71(+6.29%)
2026-06-30
TENX
TENAX THERAPEUTICS INC
7.31%660.0K$9.6M
-32.32%(-315.20K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 11.9K shares2026-Q1: 975.2K shares2026-Q2: 660.0K shares
$13.96(-86.85%)
2026-06-30
NKTR
NEKTAR THERAPEUTICS
6.41%120.7K$8.4M
+41.95%(+35.65K)
2025-Q2: 50.2K shares2025-Q3: 85.0K shares2025-Q4: 85.0K shares2026-Q1: 85.0K shares2026-Q2: 120.7K shares
$36.54(+102.15%)
2026-06-30
ADMA
ADMA BIOLOGICS INC
4.72%740.0K$6.2M
+0.00%(+0)
2025-Q2: 750.0K shares2025-Q3: 739.0K shares2025-Q4: 740.0K shares2026-Q1: 740.0K shares2026-Q2: 740.0K shares
$2.27(+318.13%)
2026-06-30
CAMP
CAMP4 THERAPEUTICS CORP
4.62%1.39M$6.1M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 228.9K shares2026-Q1: 1.39M shares2026-Q2: 1.39M shares
$5.15(-2.60%)
2026-06-30
KZIA
KAZIA THERAPEUTICS LTD
3.7%345.2K$4.9M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 460.4K shares2026-Q1: 345.2K shares2026-Q2: 345.2K shares
$7.05(+92.98%)
2026-06-30
INDV
INDIVIOR PHARMACEUTICALS INC
3.12%100.0K$4.1Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 100.0K shares
$12.65(+210.17%)
2026-06-30
CRBP
CORBUS PHARMACEUTICALS HLDGS
3.03%425.0K$4.0M
+10.83%(+41.54K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 389.9K shares2026-Q1: 383.5K shares2026-Q2: 425.0K shares
$10.11(+1.79%)
2026-06-30
MSLE
SATELLOS BIOSCIENCE INC
2.83%491.6K$3.7M
+391.62%(+391.62K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 100.0K shares2026-Q2: 491.6K shares
$6.62(+48.58%)
2026-06-30

About Stonepine Capital Management LLCโ€™s portfolio

Stonepine Capital Management LLC reports $177.26M in US-listed equity holdings across 72 positions in its most recent 13F filing. Its largest disclosed positions are VSTM (9.7%), EOLS (8.4%) and TENX (7.3%). The top 20 holdings account for 73.07% of reported assets. Its disclosed equity book has returned -18.23% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
VSTM โ€” 10.7% ($12.80M)EOLS โ€” 9.2% ($11.04M)TENX โ€” 8.0% ($9.60M)NKTR โ€” 7.0% ($8.42M)ADMA โ€” 5.2% ($6.19M)CAMP โ€” 5.1% ($6.07M)KZIA โ€” 4.1% ($4.86M)INDV โ€” 3.4% ($4.10M)CRBP โ€” 3.3% ($3.99M)MSLE โ€” 3.1% ($3.72M)Other โ€” 40.8% ($48.87M)
59%in top 10
  • VSTM10.7%
  • EOLS9.2%
  • TENX8.0%
  • NKTR7.0%
  • ADMA5.2%
  • CAMP5.1%
  • KZIA4.1%
  • INDV3.4%
  • CRBP3.3%
  • MSLE3.1%
  • Other40.8%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
10
INDVINDIVIOR PHARMACEUTICALS INC3.1%
SPRBSPRUCE BIOSCIENCES INC1.2%
MLTXMOONLAKE IMMUNOTHERAPEUTICS0.7%
AZTRAZITRA INC0.7%
+6 opened
Added to
19
EDSAEDESA BIOTECH INC+1421.5%
MSLESATELLOS BIOSCIENCE INC+391.6%
CABACABALETTA BIO INC+1734.2%
NKTRNEKTAR THERAPEUTICS+41.9%
+15 more
Trimmed
17
TENXTENAX THERAPEUTICS INC-32.3%
ZVRAZEVRA THERAPEUTICS INC-46.1%
EOLSEVOLUS INC-9.6%
ABEOABEONA THERAPEUTICS INC-25.4%
+13 more

Unlock alerts, watchlists & AI chat

Sign up free to track Stonepine Capital Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Stonepine Capital Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1440771). View Stonepine Capital Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all